Congenital and Disseminated Pyogenic Granuloma-like Vascular Lesions
S. Mallet(Aix-Marseille Université), Nicolás André(Ben-Gurion University of the Negev), Michel Wassef(Université Paris Cité), M.‐A. Richard(Ceres), Caroline Gaudy‐Marqueste(Aix-Marseille Université), Charlotte Rebelle(Institut d’Hématologie et d’Oncologie Pédiatrique), S. Hesse(Hôpital Sainte-Marguerite), Jean‐Jacques Grob(Aix-Marseille Université), Didier Scavarda(Hôpital de la Timone), Isabelle Ligi, Philippe Petit(Aix-Marseille Université), C Bouvier, Sylvie Fraitag(Hôpital Necker-Enfants Malades)
Cited by 10
Related Papers
Pembrolizumab versus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2015|5.9k
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
|The Lancet|2012|3k
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|Blood|2016|1.6k
Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies
|PEDIATRICS|2015|1.4k
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
|New England Journal of Medicine|2016|1.3k